Xylitol Cda Inc (XYLTF) 0.0432 $XYLTF Xylitol Canada

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Xylitol Cda Inc (XYLTF) 0.0432 $XYLTF

Xylitol Canada Inc. Announces Resignation of Director and Appointment of New Director, Chief Executive Officer, Chairman, and Corporate Secretary
Marketwired - Tue Jun 21, 5:16PM CDT
TORONTO, ONTARIO--(Marketwired - Jun 21, 2016) - Xylitol Canada Inc. (TSX VENTURE:XYL) ("Xylitol" or the "Company" wishes to announce the resignation of Mr. Matthew D. Willer as a director to the Xylitol Board of Directors (the "Board".
XYL.VN: 0.045 (-0.005)

Xylitol Canada Inc. Announces Closing of Convertible Debenture Financing
Marketwire Canada - Fri Jun 10, 4:04PM CDT
TORONTO, ONTARIO--(Marketwired - Jun 10, 2016) - Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE:XYL) is pleased to announce that it has issued convertible debentures (the "Debentures", on a private placement basis, for aggregate gross proceeds of $410,000, representing a third tranche of the previously announced offering of Debentures for aggregate gross proceeds of up to $3 million (the "Offering", as announced on February 8, 2016, and March 15, 2016. The Debentures are convertible into common shares of the Company at a price of $0.10 per share, have a maturity date that is three years from the date of issuance, and accrue interest at a rate of 10% per annum. The Company also issued an aggregate of 820,000 share purchase warrants (the "Warrants" to Debenture subscribers, each Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price $0.15 per share, for a period of three years from date of issuance.
XYL.VN: 0.045 (-0.005)

Xylitol Canada Inc. Financial Results for Three Months Ended March 31, 2016
Marketwired - Thu May 26, 4:31PM CDT
TORONTO, ONTARIO--(Marketwired - May 26, 2016) - Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE:XYL) today announces that it has released its financial and operating results for the three months ended March 31, 2016.
XYL.VN: 0.045 (-0.005)

Xylitol Canada Inc.: Financial Results for Three and Twelve Months Ended December 31, 2015
Marketwired - Fri Apr 29, 3:50PM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) today announces that it has released its financial and operating results for the Fiscal year ending December 31, 2015 in addition to the 4th Quarter results for the period of October 1, 2015 to December 31, 2015.
XYL.VN: 0.045 (-0.005)

Dundee Corporation Acquires Further Interest in Xylitol Canada Inc.
Marketwired - Tue Apr 12, 4:01PM CDT
In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) ("Dundee" announces that it has acquired, through a wholly owned subsidiary, a $250,000 secured convertible debenture, as part of a secured financing and a $250,000 unsecured convertible debenture, as part of an unsecured financing (together the "Debentures" of Xylitol Canada Inc. ("Xylitol". The Debentures are convertible into common shares of Xylitol at a price of $0.10 per share. As part of the secured financing, Dundee received 2,500,000 warrants, each warrant being exercisable into one common share of Xylitol at $0.08 for a period of two years. As part of the unsecured financing, Dundee received 500,000 warrants, each warrant being exercisable into one common share of Xylitol at $0.15 for a period of 18 months.
DC-A.TO: 7.59 (+0.18)

Xylitol Canada Inc. Issues Secured Convertible Debentures to Fountain Asset Corp. and Other Subscribers
Marketwired - Mon Apr 11, 7:09PM CDT
Fountain Asset Corp. (TSX VENTURE: FA) ("Fountain" and Xylitol Canada Inc. (TSX VENTURE: XYL) ("Xylitol" are pleased to announce the completion of a secured convertible debenture financing (the "Secured Financing" in the principal amount of $1,000,000. Fountain's total participation was $710,000 of the Secured Financing. The net proceeds of the Financing shall be used to as working capital for Xylitol to increase their product sales within the North American natural foods market.
XYL.VN: 0.045 (-0.005), FA.VN: 0.290 (unch)

Xylitol Canada Inc. Announces Closing of Tranche 2 of Convertible Debenture Financing
Marketwired - Tue Mar 15, 4:56PM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) is pleased to announce that it has issued convertible debentures (the "Debentures", on a private placement basis, for aggregate gross proceeds of $400,000, representing a second tranche of the previously announced offering of Debentures for aggregate gross proceeds of up to $3 million (the "Offering", as previously announced on February 8, 2016. The Debentures are convertible into common shares of the company at a price of $0.10 per share, have a maturity date that is three years from the date of issuance, and accrue interest at a rate of 10% per annum. The Company also issued an aggregate of 800,000 share purchase warrants (the "Warrants" to Debenture subscribers, each Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price $0.15 per share, for a period of three years from date of issuance.
XYL.VN: 0.045 (-0.005)

IIROC Trade Resumption - Xylitol Canada Inc.
Newsfile Corp - Mon Feb 08, 3:17PM CST
Trading resumes in:

Xylitol Canada Announces Appointment and Resignation of Directors
Marketwired - Mon Feb 08, 2:40PM CST
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) is pleased to announce that Matt Willer has been appointed to the board of directors of the Company.
XYL.VN: 0.045 (-0.005)

IIROC Trade Halt - Xylitol Canada Inc.
Newsfile Corp - Mon Feb 08, 11:22AM CST
The following issues have been halted by IIROC:

IIROC Trading Halt - XYL
CNW Group - Mon Feb 08, 11:17AM CST
The following issues have been halted by IIROC:
XYL.VN: 0.045 (-0.005)

Xylitol Canada Announces Resignation of Chief Executive Officer
Marketwire Canada - Fri Feb 05, 4:37PM CST
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE:XYL) announced today that Andrew Reid has resigned from his duties as President, Chief Executive Officer, and a director of the Company, effective immediately. The Board of Directors has initiated a search process to identify an appropriate replacement for Mr. Reid as President and Chief Executive Officer.
XYL.VN: 0.045 (-0.005)

Xylitol Canada Inc. Announces Termination of Brokered Private Placement
Marketwired - Mon Nov 30, 3:31PM CST
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) announces today that due to market conditions the Company has terminated its previously announced private placement for gross proceeds of up to CAD $3,000,000 through a brokered private placement led by Mackie Research Capital Corporation.
XYL.VN: 0.045 (-0.005)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading